drugset / Trial / NCT01198756

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children

NCT01198756

Phase 3 Completed 3109 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindPrevention

Summary

This study is designed to test the immunogenicity and safety of an investigational influenza vaccine, in children compared to two other influenza vaccines.

Timeline

Start
2010-10-01
Primary completion
2011-07-01
Completion
2011-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluarix™ VB Vaccine Intramuscular
Comparator Fluarix™ YB Vaccine Intramuscular
Subject GSK2282512A Vaccine Intramuscular

Indications